The week in review

Vaccination was the hot topic this week, with the COVID-19 jab rollout running into trouble

First, we learned that the COVID-19 vaccine rollout in community pharmacy would be delayed by a month, until June. Then it was announced that the use of AstraZeneca’s vaccine would be restricted in under 50’s due to a rare clotting event.

Just before the news broke about the AstraZeneca vaccine, NSW Premier Gladys Berejiklian announced the state government would open a mass vaccination hub at Homebush, which was queried by Pharmacy Guild national president Trent Twomey. “Assuming I’m in a city near a footy stadium, I’d have to take time off work during the week, then have to get to the stadium in the traffic probably with my young family in tow, wait for hours for my shot in close quarters with hundreds of others, putting us all at greater risk of community transmission, and then wait around, then to find a way home for all of us,” he said. “Why wouldn’t I just want to go to my pharmacy down the road from home on a weekend?”

Meanwhile, the Guild is again lobbying for the extension of access by community pharmacies in all States and Territories to vaccines under the National Immunisation Program (NIP); and we found out which Australians are seeking their flu shot in pharmacies.

The Pharmacy Board offered its latest snapshot of the profession, including a jump in member numbers. And the Pharmacy and Medical Boards published a joint reminder on the dangers of incorrect methotrexate dosing.

Are you practising but looking or working outside pharmacy? Tell us in our latest poll here!

Previous Vaccine woes
Next Electronic execution and remote witnessing

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply